Ra Capital Management as of Sept. 30, 2021
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 95 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 16.3 | $1.2B | 7.4M | 159.39 | |
| Novavax Com New (NVAX) | 6.0 | $435M | 2.1M | 207.31 | |
| Eliem Therapeutics (ELYM) | 3.3 | $237M | 13M | 17.98 | |
| Adagio Therapeutics (IVVD) | 3.1 | $226M | 5.3M | 42.24 | |
| Forma Therapeutics Hldgs SHS | 2.9 | $209M | 9.0M | 23.19 | |
| Cytek Biosciences (CTKB) | 2.9 | $206M | 9.6M | 21.41 | |
| Atea Pharmaceuticals (AVIR) | 2.6 | $190M | 5.4M | 35.06 | |
| Janux Therapeutics (JANX) | 2.6 | $188M | 8.7M | 21.63 | |
| Vor Biopharma (VOR) | 2.4 | $174M | 11M | 15.68 | |
| Aerovate Therapeutics (AVTE) | 2.4 | $173M | 8.3M | 20.98 | |
| Icosavax | 2.4 | $171M | 5.8M | 29.59 | |
| Dice Therapeutics | 2.4 | $171M | 5.2M | 32.75 | |
| Connect Biopharma Hldgs Ads (CNTB) | 2.3 | $169M | 7.0M | 24.23 | |
| Nkarta (NKTX) | 2.2 | $156M | 5.6M | 27.81 | |
| Acumen Pharmaceuticals (ABOS) | 2.0 | $145M | 9.8M | 14.86 | |
| Tg Therapeutics (TGTX) | 1.9 | $136M | 4.1M | 33.28 | |
| Travere Therapeutics (TVTX) | 1.9 | $136M | 5.6M | 24.25 | |
| Tyra Biosciences (TYRA) | 1.8 | $127M | 7.2M | 17.59 | |
| Macrogenics (MGNX) | 1.7 | $125M | 5.9M | 20.94 | |
| Iteos Therapeutics (ITOS) | 1.7 | $119M | 4.4M | 27.00 | |
| Day One Biopharmaceuticals I (DAWN) | 1.6 | $118M | 5.0M | 23.73 | |
| ImmunoGen | 1.4 | $104M | 18M | 5.67 | |
| Phathom Pharmaceuticals (PHAT) | 1.4 | $100M | 3.1M | 32.10 | |
| Vaxcyte (PCVX) | 1.4 | $99M | 3.9M | 25.37 | |
| 89bio (ETNB) | 1.3 | $97M | 5.0M | 19.59 | |
| Instil Bio | 1.2 | $87M | 4.9M | 17.87 | |
| Celldex Therapeutics Com New (CLDX) | 1.2 | $86M | 1.6M | 53.99 | |
| Kinnate Biopharma (KNTE) | 1.1 | $83M | 3.6M | 23.02 | |
| Werewolf Therapeutics (HOWL) | 1.0 | $74M | 4.3M | 17.16 | |
| Tenaya Therapeutics (TNYA) | 1.0 | $73M | 3.6M | 20.65 | |
| Point Biopharma Global | 0.9 | $68M | 8.9M | 7.69 | |
| Gh Research Ordinary Shares (GHRS) | 0.9 | $67M | 3.0M | 22.06 | |
| Rhythm Pharmaceuticals (RYTM) | 0.9 | $64M | 4.9M | 13.06 | |
| Rocket Pharmaceuticals (RCKT) | 0.9 | $63M | 2.1M | 29.89 | |
| C4 Therapeutics Com Stk (CCCC) | 0.9 | $62M | 1.4M | 44.68 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.8 | $60M | 3.6M | 16.70 | |
| Olema Pharmaceuticals (OLMA) | 0.8 | $59M | 2.2M | 27.56 | |
| Cyteir Therapeutics | 0.8 | $59M | 3.4M | 17.55 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $51M | 1.7M | 29.80 | |
| Zogenix Com New | 0.7 | $51M | 3.3M | 15.19 | |
| Dyne Therapeutics (DYN) | 0.6 | $46M | 2.8M | 16.24 | |
| Graphite Bio | 0.6 | $44M | 2.7M | 16.39 | |
| Edgewise Therapeutics (EWTX) | 0.6 | $43M | 2.6M | 16.60 | |
| Verve Therapeutics (VERV) | 0.6 | $41M | 880k | 47.00 | |
| Geron Corporation (GERN) | 0.6 | $41M | 30M | 1.37 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.5 | $39M | 5.0M | 7.79 | |
| Rxsight (RXST) | 0.5 | $39M | 3.1M | 12.67 | |
| Wave Life Sciences SHS (WVE) | 0.5 | $38M | 7.8M | 4.90 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $34M | 1.9M | 17.45 | |
| Design Therapeutics (DSGN) | 0.4 | $32M | 2.2M | 14.69 | |
| Bolt Biotherapeutics (BOLT) | 0.4 | $30M | 2.4M | 12.65 | |
| Solid Biosciences | 0.4 | $30M | 12M | 2.39 | |
| Tango Therapeutics (TNGX) | 0.4 | $29M | 2.3M | 12.93 | |
| Kala Pharmaceuticals | 0.4 | $29M | 11M | 2.62 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.4 | $28M | 5.1M | 5.48 | |
| Satsuma Pharmaceuticals Ord | 0.4 | $28M | 5.9M | 4.66 | |
| Akouos | 0.4 | $27M | 2.3M | 11.61 | |
| Orchard Therapeutics Ads | 0.4 | $25M | 11M | 2.30 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.3 | $23M | 2.2M | 10.42 | |
| Century Therapeutics (IPSC) | 0.3 | $23M | 914k | 25.16 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $22M | 2.6M | 8.46 | |
| Synlogic | 0.3 | $20M | 6.7M | 3.05 | |
| Scpharmaceuticals (SCPH) | 0.3 | $18M | 2.7M | 6.65 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $18M | 3.5M | 5.09 | |
| Larimar Therapeutics (LRMR) | 0.2 | $18M | 1.5M | 11.53 | |
| Silverback Therapeutics (SPRY) | 0.2 | $17M | 1.7M | 9.98 | |
| Nautilus Biotechnology (NAUT) | 0.2 | $15M | 2.4M | 6.14 | |
| Da32 Life Scnce Class A Com | 0.2 | $15M | 1.5M | 9.83 | |
| Milestone Pharmaceuticals (MIST) | 0.2 | $13M | 2.2M | 5.71 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $13M | 1.3M | 9.96 | |
| Astria Therapeutics (ATXS) | 0.2 | $11M | 1.3M | 8.84 | |
| Entera Bio SHS (ENTX) | 0.2 | $11M | 2.4M | 4.71 | |
| Tscan Therapeutics (TCRX) | 0.1 | $11M | 1.3M | 8.34 | |
| Avidity Biosciences Ord (RNA) | 0.1 | $10M | 424k | 24.63 | |
| Aadi Bioscience (AADI) | 0.1 | $10M | 348k | 29.37 | |
| Fs Development Corp Ii Com Cl A | 0.1 | $10M | 1.0M | 9.95 | |
| Concert Pharmaceuticals I equity | 0.1 | $9.9M | 3.0M | 3.27 | |
| Arya Sciences Acquisitn Corp Class A Ord Shs | 0.1 | $9.9M | 1.0M | 9.88 | |
| Frazier Lifesciences Acquisition Cl A Shs | 0.1 | $9.8M | 1.0M | 9.82 | |
| Ikena Oncology (IKNA) | 0.1 | $9.5M | 750k | 12.62 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.1 | $8.9M | 2.9M | 3.11 | |
| Cue Health (HLTH) | 0.1 | $8.9M | 750k | 11.81 | |
| Cogent Biosciences (COGT) | 0.1 | $8.6M | 1.0M | 8.41 | |
| Cullinan Oncology (CGEM) | 0.1 | $7.9M | 350k | 22.57 | |
| Ocular Therapeutix (OCUL) | 0.1 | $7.5M | 750k | 10.00 | |
| 5 01 Acquisition Corp Com Cl | 0.1 | $7.4M | 750k | 9.82 | |
| Helix Acquisition Corp Com Cl A | 0.1 | $7.0M | 700k | 9.95 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $6.2M | 625k | 9.89 | |
| Biomea Fusion (BMEA) | 0.1 | $6.0M | 500k | 11.97 | |
| CVRX (CVRX) | 0.1 | $4.5M | 275k | 16.54 | |
| Syros Pharmaceuticals | 0.1 | $4.0M | 900k | 4.47 | |
| Chemocentryx | 0.1 | $3.7M | 219k | 17.10 | |
| Otonomy | 0.0 | $3.1M | 1.6M | 1.92 | |
| Reneo Pharmaceuticals (RPHM) | 0.0 | $464k | 62k | 7.46 | |
| Miragen Therapeutics (VRDN) | 0.0 | $17k | 1.0k | 16.44 |
